Surgical staging has become the standard of care for the treatment of women
with endometrial cancer. Recent scientific publications have confirmed the
relative safety of this procedure when performed by subspecialty trained s
urgeons and have provided compelling evidence that the routine use of posto
perative teletherapy is not cost effective, nor does it offer improved surv
ival. New questions as to the safety and effectiveness of a laparoscopic st
aging approach have been answered in the affirmative. Although the extent o
f staging has not yet been defined, growing evidence suggests that preopera
tive studies and intraoperative clinical opinion cannot be consistently cou
nted on to be predictive of postoperative histologic status. Therefore, all
patients should be considered at risk and should undergo an operation in a
clinical situation that offers the immediate availability of retroperitone
al staging or cytoreductive surgery if necessary. Curr Opin Oncol 2001, 13:
408-412 (C) 2001 Lippincott Williams & Wilkins, Inc.